Platelet-activating factor dilates efferent arterioles through glomerulus-derived nitric oxide

Journal of the American Society of Nephrology

Volumn 7, Issue 1, 1996, Pages 90-96

  Arima, Shuji ^a   Ren, YiLin ^a   Juncos, Luis A ^a   Ito, Sadayoshi ^a,b  

^a HENRY FORD HOSPITAL   (United States)

^b TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Cyclooxygenase; Glomerular hemodynamics; Rabbit

Indexed keywords

INDOMETACIN; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NORADRENALIN; PROSTAGLANDIN SYNTHASE; THROMBOCYTE ACTIVATING FACTOR;

ANIMAL EXPERIMENT; ARTERIOLE; ARTICLE; GLOMERULUS; KIDNEY BLOOD FLOW; NONHUMAN; PRIORITY JOURNAL; RABBIT; VASODILATATION;

EID: 0030028978     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Braquet P, Touqui L, Shen TY, Vargaftig BB: Perspectives in platelet-activating factor research. Pharmacol Rev 1987;39:97-145.
2. Benveniste J, Henson PM, Cochrane CG: Leukocyte dependent histamine release from rabbit platelets. J Exp Med 1972;136:1356-1377.
3. Schlondorff D, Neuwirth R: Platelet-activating factor and the kidney. Am J Physiol 1986;251:F1-F11.
4. Zanglis A, Lianos EA: Platelet-activating factor biosynthesis and degradation in rat glomeruli. J Lab Clin Med 1987;110:330-337.
5. Lianos EA, Zanglis A: Biosynthesis and metabolism of 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine in rat glomerular mesangial cells. J Biol Chem 1987;262: 8990-8993.
6. Bertani T, Livio M, MacConi D, et al.: Platelet-activating factor (PAF) as the mediator of injury in nephrotoxic nephritis. Kidney Int 1987;31:1248-1256.
7. Camussi G, Pawiowski I, Saunders R, Brentjens J, Andres G: Receptor antagonist of platelet-activating factor inhibits inflammatory injury induced by in situ formation of immune complexes in renal glomeruli and in the skin. J Lab Clin Med 1987;110:196-206.
8. 2. Am J Physiol 1989;256:F35-F43.
9. Juncos LA, Ren Y, Arima S, Ito S: Vasodilator and constrictor actions of platelet-activating factor in the isolated microperfused afferent arteriole of the rabbit kidney. J Clin Invest 1993;91:1374-1379.
10. Arima S, Ren YL, Juncos LA, Carretero OA, Ito S: Glomerular prostaglandins modulate vascular reactivity of the downstream efferent arterioles. Kidney Int 1994; 45:650-658.
11. Ito S, Arima S, Ren YL, Juncos LA, Carretero OA: Endothelium-derived relaxing factor/nitric oxide modulates angiotensin II action in the isolated microperfused rabbit afferent but not efferent arteriole. J Clin Invest 1993;91:2012-2019.
12. Snyder F: Platelet-activating factor and related acetylated lipids as potent biologically active cellular mediators. Am J Physiol 1990;259:C697-C708.
13. Caramelo C, Fernandes-Gallardo S, Marin-Cao D, et al.: Presence of platelet-activating factor in blood from humans and experimental animals: Its absence in anephric individuals. Biochem Biophys Res Commun 1984;120: 789-796.
14. Lee TC, Malone B, Woodward D, Snyder F: Renal necrosis and the involvement of a single enzyme of the de novo pathway for the biosynthesis of platelet-activating factor in rat kidney inner medulla. Biochem Biophys Res Commun 1989;163:1002-1005.
15. McGowan HM, Vandongen R, Kelly LD, Hilly KJ: Increased levels of platelet-activating factor (1-O-alkyl-2-acetylglycero-phosphocholine) in blood after reversal of renal clip hypertension in the rat. Clin Sci 1988;74:393-396.
16. Muirhead EE, Byers LW, Desiderio DM, Brooks B, Brosius WM: Antihypertensive lipids from the kidney: Alkyl ether analogs of phosphatidylcholine. Fed Proc 1981;40:2285-2290.
17. Schlondorff D, Goldwasser P, Neuwirth R, Satriano J, Clay K: Production of platelet-activating factor in glomeruli and cultured glomerular mesangial cells. Am J Physiol 1986;250:F1123-1127.
18. 2 synthesis, arachidonic acid release, and contraction of cultured rat mesangial cells. J Clin Invest 1984;73:1227-1231.
19. Handa RK, Strandhoy JW, Bucklew VM Jr: Platelet-activating factor is a renal vasodilator in the anesthetized rat. Am J Physiol 1990;258:F1504-F1509.
20. Schwertschlag U, Schert H, Gerber JG, Mathias M, Nies AS: Platelet activating factor induces changes on renal vascular resistance, vascular reactivity, and renin release in the isolated perfused rat kidney. Circ Res 1987; 60:534-539.
21. Marsden PA, Brock TS, Ballermann BJ: Glomerular endothelial cells respond to calcium mobilizing agonists with release of EDRF. Am J Physiol 1990;258:F1295-F1303.
22. Loutzenhiser R, Hayashi K, Epstein M: Divergent effects of KCl-induced depolarization on afferent and efferent arterioles. Am J Physiol 1989;257:F561-F564.
23. Tare M, Parkington HC, Coleman HA, Neild TO, Dusting JG: Hyperpolarization and relaxation of arterial smooth muscle caused by nitric oxide derived from the endothelium. Nature 1990;346:69-71.
24. Plante G, Herbert RL, Braquet P, Sirois P: Hemodynamic effects of PAF acether. Pharmacol Res Commun 1986;18[Suppl]:173-179.
25. Prescott SM, Zimmerman GA, Mcintyre TM: Platelet-activating factor. J Biol Chem 1990;265:17381-17384.
26. Schwertschlag US, Whorton AR: Platelet-activating factor-induced homologous and heterologous desensitization in cultured vascular smooth muscle cells. J Biol Chem 1988;263:13791-13796.
27. Camussi G: Potential role of platelet-activating factor in renal pathophysiology. Kidney Int 1986;29:469-477.
28. Remuzzi G: Eicosanoids and platelet-activating factor as possible mediators of injury in experimental nephropathies. Adv Exp Med Biol 1989;259:221-247.
29. Baldi E, Emancipator SN, Hassan MO, Dunn MJ: Platelet-activating factor receptor blockade ameliorates murine systemic lupus erythematosus. Kidney Int 1990;38: 1030-1038.
30. Lanese DM, Conger JD: Endothelin (ET)-induced vasoconstriction is mediated by platelet activating factor (PAF) in the afferent arteriole (AA) but not the efferent arteriole (EA) [Abstract]. J Am Soc Nephrol 1992;3:565A.
31. Nicola LD, Thompson SC, Wead LM, Brown MR, Gabbai FB: Arginine feeding modifies cyclosporine nephrotoxicity in rats. J Clin Invest 1993;92:1859-1865.